Is There a Vaccine for Class Actions, Too?

February 3, 2021


Download Slides

The past year brought multiple developments affecting not only how corporations litigate class actions, but how aggregate litigation will be addressed in the future.

Members of McGuireWoods’ class action team discuss the controversies that surrounded class action practice in 2020 and what they mean for 2021 and beyond.


  • Matthew C. Kane, Partner
  • Bethany Gayle Lukitsch, Partner
  • R. Trent Taylor, Partner
  • Bryan A. Fratkin, Partner (Moderator)

Who Should Attend

Executives, in-house counsel, government employees, lawyers and anyone else interested in learning more about recent class action decisions

Our programs are intended for the benefit of our clients and contacts and we reserve the right to refuse any registration at our sole discretion.
Video and presentation materials © 2021 McGuireWoods LLP. All rights reserved.